You have 9 free searches left this month | for more free features.

angiogenesis, VEGF

Showing 1 - 25 of 2,256

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Angiogenesis, Colon Cancer, Surgery Trial (Surgery for colon cancer with intention to cure)

Active, not recruiting
  • Angiogenesis
  • +4 more
  • Surgery for colon cancer with intention to cure
  • (no location specified)
Apr 14, 2021

Retinal Pigment Epithelium Detachment in Neovascular Age-related

Active, not recruiting
  • Neovascular Age-related Macular Degeneration
  • Anti-vascular endothelial growth factor therapy
  • Krasnodar, Russian Federation
    The S.N. Fyodorov Eye Microsurgery State Institution
Jan 12, 2022

Angiogenesis, Endometriosis Trial in Patra, Yonago (Leuprolide Acetate)

Completed
  • Angiogenesis
  • Endometriosis
  • Leuprolide Acetate
  • Patra, Peloponnese, Greece
  • +1 more
Oct 27, 2023

Colorectal Cancer, Angiogenesis Trial in Barcelona (COLORECTAL CANCER SURGERY)

Unknown status
  • Colorectal Cancer
  • Angiogenesis
  • COLORECTAL CANCER SURGERY
  • Barcelona, Spain
    Hospital de la Santa Creu i Sant Pau
Oct 29, 2019

Recovery in Post-stroke Rehabilitation

Completed
  • Ischemic Stroke
    • Lodz, Poland
      Medical University of Lodz
    Feb 20, 2023

    Covid19, Angiogenesis, Endothelial Dysfunction Trial in Independencia (Endothelial damage and angiogenic biomarkers)

    Completed
    • Covid19
    • +3 more
    • Endothelial damage and angiogenic biomarkers
    • Independencia, Santiago, Chile
      Hospital Clínico de la Universidad de Chile
    Jan 5, 2023

    Peripheral Arterial Disease Trial in Louisville (Carnosine, Placebo)

    Completed
    • Peripheral Arterial Disease
    • Louisville, Kentucky
      University of Louisville
    Aug 3, 2022

    MPM Trial in Changchun (PM8002, Pemetrexed, Cisplatin)

    Recruiting
    • MPM
    • Changchun, China
      Jilin Provincial Tumor Hospital
    Jun 25, 2023

    in Vitro Fertilization, Poor Responder Trial in Toronto (metoclopramide)

    Withdrawn
    • in Vitro Fertilization
    • Poor Responder
    • Toronto, Ontario, Canada
      Mount Sinai Hospital
    Apr 7, 2022

    Neuroendocrine Tumors Trial in Copenhagen (One injection of 68Ga-NODAGA-E[c(RGDyK)]2, PET/CT)

    Completed
    • Neuroendocrine Tumors
    • One injection of 68Ga-NODAGA-E[c(RGDyK)]2
    • PET/CT
    • Copenhagen, Denmark
      Department of Clinical Physiology, Nuclear Medicine and PET, Rig
    Jun 28, 2022

    Peripheral Arterial Disease Trial in Louisville (Carnosine)

    Not yet recruiting
    • Peripheral Arterial Disease
    • Carnosine
    • Louisville, Kentucky
      University of Louisville
    Nov 16, 2022

    Ovarian Cancer, Fallopian Tube Adenocarcinoma, Fallopian Tube Carcinosarcoma Trial in Seattle (Exercise Counseling, Aerobic

    Terminated
    • Ovarian Cancer
    • +21 more
    • Exercise Counseling
    • +5 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 6, 2022

    MRI Characterization of Mammographically Detected DCIS

    Recruiting
    • Breast Cancer, Stage 0
    • Breast MRI
    • Laboratory Biomarker Analysis
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jul 21, 2022

    Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion Trial in Shanghai (BD311)

    Recruiting
    • Neovascular Age-related Macular Degeneration
    • +2 more
    • BD311
    • Shanghai, Shanghai, China
      Eye & ENT Hospital of Fudan University
    Aug 22, 2022

    Metastatic Colorectal Carcinoma Trial (Pentoxifylline, FOLFOX, XELOX)

    Not yet recruiting
    • Metastatic Colorectal Carcinoma
    • (no location specified)
    Nov 1, 2023

    Pheochromocytoma, Paraganglioma Trial in New York (Axitinib)

    Recruiting
    • Pheochromocytoma
    • Paraganglioma
    • New York, New York
      Columbia University Irving Medical Center
    Oct 5, 2022

    AMD, nAMD, Wet Age-related Macular Degeneration Trial in United States (RGX-314 Dose 1, RGX-314 Dose 2, Aflibercept (EYLEA®))

    Recruiting
    • AMD
    • +5 more
    • RGX-314 Dose 1
    • +2 more
    • Encino, California
    • +16 more
    Jun 2, 2022

    CD34 + Stem Cells and Biological Markers of Angiogenesis in

    Recruiting
    • Vasculopathy
    • Heart Transplant Failure
    • coronary CT angiography
    • Ljubljana, Slovenia
      Advanced Heart Failure and Transplantation Center, University Me
    Aug 2, 2022

    Solid Tumor, Adult, Solid Tumor, Gastric Cancer Trial in Seongnam, Seoul (PB101)

    Recruiting
    • Solid Tumor, Adult
    • +5 more
    • Seongnam, Korea, Republic of
    • +2 more
    Oct 11, 2023

    Angiogenesis Polymorphisms In HCC Patients Treated With

    Unknown status
    • Hepatocellular Carcinoma
    • blood sample collection
    • Bari, BA, Italy
    • +9 more
    Feb 25, 2021

    Candidate Molecules in Laryngeal Carcinoma

    Completed
    • Larynx Cancer
    • Larynx Carcinoma
    • Obtaining blood samples
    • Ankara, Turkey
      Hacettepe University Cancer Institute Dept. of Basic Oncology
    Jan 19, 2022

    Thyroid Eye Disease Trial in Boston (Sub-tenon injection of saline followed by a sub-tenon injection of aflibercept, Sub-tenon

    Recruiting
    • Thyroid Eye Disease
    • Sub-tenon injection of saline followed by a sub-tenon injection of aflibercept
    • +2 more
    • Boston, Massachusetts
      Mass Eye and Ear
    Feb 8, 2022

    Ovarian Cancer Stage IV Trial in France (Pembrolizumab Injectable Product - Chemotherapy - Bevacizumab, Chemotherapy -

    Active, not recruiting
    • Ovarian Cancer Stage IV
    • Pembrolizumab Injectable Product - Chemotherapy - Bevacizumab
    • Chemotherapy - Bevacizumab
    • Avignon, France
    • +16 more
    Feb 15, 2022

    Hepatocellular Carcinoma Trial (PD-1/PD-L1 inhibitors+VEGF-TKI/bevacizumab, TACE)

    Recruiting
    • Hepatocellular Carcinoma
    • PD-1/PD-L1 inhibitors+VEGF-TKI/bevacizumab
    • TACE
    • Nanjing, China
    • +1 more
    Dec 28, 2022

    Diabetic Retinopathy, Dyslipidemias, Diabetes Trial (Fenofibrate, Placebo)

    Completed
    • Diabetic Retinopathy
    • +2 more
    • (no location specified)
    May 9, 2021